1. Home
  2. OCSL vs PBMWW Comparison

OCSL vs PBMWW Comparison

Compare OCSL & PBMWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCSL
  • PBMWW
  • Stock Information
  • Founded
  • OCSL 2007
  • PBMWW N/A
  • Country
  • OCSL United States
  • PBMWW Canada
  • Employees
  • OCSL N/A
  • PBMWW 10
  • Industry
  • OCSL Finance: Consumer Services
  • PBMWW
  • Sector
  • OCSL Finance
  • PBMWW
  • Exchange
  • OCSL Nasdaq
  • PBMWW Nasdaq
  • Market Cap
  • OCSL 1.3B
  • PBMWW N/A
  • IPO Year
  • OCSL 2008
  • PBMWW N/A
  • Fundamental
  • Price
  • OCSL $15.26
  • PBMWW $0.01
  • Analyst Decision
  • OCSL Hold
  • PBMWW
  • Analyst Count
  • OCSL 9
  • PBMWW 0
  • Target Price
  • OCSL $17.29
  • PBMWW N/A
  • AVG Volume (30 Days)
  • OCSL 1.1M
  • PBMWW N/A
  • Earning Date
  • OCSL 01-30-2025
  • PBMWW N/A
  • Dividend Yield
  • OCSL 14.40%
  • PBMWW N/A
  • EPS Growth
  • OCSL N/A
  • PBMWW N/A
  • EPS
  • OCSL 0.72
  • PBMWW N/A
  • Revenue
  • OCSL $381,665,000.00
  • PBMWW N/A
  • Revenue This Year
  • OCSL N/A
  • PBMWW N/A
  • Revenue Next Year
  • OCSL N/A
  • PBMWW N/A
  • P/E Ratio
  • OCSL $21.22
  • PBMWW N/A
  • Revenue Growth
  • OCSL 0.63
  • PBMWW N/A
  • 52 Week Low
  • OCSL $14.95
  • PBMWW N/A
  • 52 Week High
  • OCSL $21.64
  • PBMWW N/A
  • Technical
  • Relative Strength Index (RSI)
  • OCSL 43.19
  • PBMWW N/A
  • Support Level
  • OCSL $14.95
  • PBMWW N/A
  • Resistance Level
  • OCSL $15.35
  • PBMWW N/A
  • Average True Range (ATR)
  • OCSL 0.23
  • PBMWW 0.00
  • MACD
  • OCSL -0.01
  • PBMWW 0.00
  • Stochastic Oscillator
  • OCSL 31.52
  • PBMWW 0.00

About OCSL Oaktree Specialty Lending Corporation

Oaktree Specialty Lending Corp is a specialty finance company. The company provides lending services and invests in small and mid-sized companies. The company's investment objective is to maximize its portfolio's total return by generating current income from debt investments, and to a lesser extent, capital appreciation from equity investments. The company provides customized, one-stop credit solutions to companies with limited access to public or syndicated capital markets.

About PBMWW Psyence Biomedical Ltd. Warrant

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

Share on Social Networks: